DD209833A5 - Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen - Google Patents
Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen Download PDFInfo
- Publication number
- DD209833A5 DD209833A5 DD83250187A DD25018783A DD209833A5 DD 209833 A5 DD209833 A5 DD 209833A5 DD 83250187 A DD83250187 A DD 83250187A DD 25018783 A DD25018783 A DD 25018783A DD 209833 A5 DD209833 A5 DD 209833A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- general formula
- spiro
- hydrogen atom
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
DD209833A5 true DD209833A5 (de) | 1984-05-23 |
Family
ID=9273425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD83250187A DD209833A5 (de) | 1982-04-27 | 1983-04-25 | Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS5910584A (sv) |
KR (1) | KR840004428A (sv) |
AT (1) | ATA125383A (sv) |
AU (1) | AU1395383A (sv) |
BE (1) | BE896572A (sv) |
DD (1) | DD209833A5 (sv) |
DE (1) | DE3315106A1 (sv) |
DK (1) | DK183583A (sv) |
ES (1) | ES8405796A1 (sv) |
FR (1) | FR2525603A1 (sv) |
GB (1) | GB2133401B (sv) |
GR (1) | GR78481B (sv) |
IL (1) | IL68497A0 (sv) |
IT (1) | IT1167123B (sv) |
LU (1) | LU84770A1 (sv) |
MA (1) | MA19783A1 (sv) |
NL (1) | NL8301476A (sv) |
NO (1) | NO831473L (sv) |
OA (1) | OA07412A (sv) |
PT (1) | PT76595B (sv) |
SE (1) | SE8302347L (sv) |
ZA (1) | ZA832927B (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
MXPA05013364A (es) | 2003-06-17 | 2006-03-17 | Arena Pharm Inc | Procedimiento para preparar 3-benzazepinas. |
CN101792417A (zh) | 2003-06-17 | 2010-08-04 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
SI1838677T1 (sl) | 2004-12-21 | 2010-01-29 | Arena Pharm Inc | Kristalne oblike (R)-8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepin hidroklorida |
EA015012B1 (ru) | 2004-12-23 | 2011-04-29 | Арена Фармасьютикалз, Инк. | Композиция, содержащая фентермин и избирательный агонист рецептора 5ht, и ее применение |
SG10201508066VA (en) | 2006-04-03 | 2015-10-29 | Arena Pharm Inc | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
ES2522587T3 (es) | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
EP2443080A2 (en) | 2009-06-18 | 2012-04-25 | Arena Pharmaceuticals, Inc. | Process for the preparation of 5-ht2c receptor agonists |
WO2011153206A1 (en) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
EP2611782A1 (en) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
KR20180118801A (ko) | 2010-09-01 | 2018-10-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태 |
EP2611433A2 (en) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
SG188365A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
KR20190128001A (ko) | 2012-10-09 | 2019-11-13 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-26 SE SE8302347A patent/SE8302347L/sv not_active Application Discontinuation
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DK183583D0 (da) | 1983-04-26 |
ZA832927B (en) | 1984-06-27 |
IT8348155A0 (it) | 1983-04-26 |
KR840004428A (ko) | 1984-10-15 |
MA19783A1 (fr) | 1983-12-31 |
ES521895A0 (es) | 1984-06-16 |
GB2133401A (en) | 1984-07-25 |
SE8302347L (sv) | 1983-10-28 |
GR78481B (sv) | 1984-09-27 |
GB8311508D0 (en) | 1983-06-02 |
IL68497A0 (en) | 1983-07-31 |
OA07412A (fr) | 1984-11-30 |
LU84770A1 (fr) | 1984-11-28 |
IT1167123B (it) | 1987-05-13 |
PT76595B (fr) | 1986-01-21 |
DK183583A (da) | 1983-10-28 |
GB2133401B (en) | 1985-10-23 |
FR2525603A1 (fr) | 1983-10-28 |
NL8301476A (nl) | 1983-11-16 |
DE3315106A1 (de) | 1983-11-03 |
AU1395383A (en) | 1983-11-03 |
ES8405796A1 (es) | 1984-06-16 |
PT76595A (fr) | 1983-05-01 |
SE8302347D0 (sv) | 1983-04-26 |
JPS5910584A (ja) | 1984-01-20 |
FR2525603B1 (sv) | 1984-09-14 |
BE896572A (fr) | 1983-10-26 |
NO831473L (no) | 1983-10-28 |
ATA125383A (de) | 1986-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD209833A5 (de) | Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen | |
AT392790B (de) | Verfahren zur herstellung von neuen 2,3-dihydro-2-oxo-1h-imidazo-(4,5-b)-chinolinyletherderivaten und den pharmazeutisch vertraeglichen salzen davon | |
EP0204349A2 (de) | Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
EP0111873A1 (de) | Derivate der cis, endo-2-Azabicyclo-(5.3.0)-decan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung | |
DD146602A5 (de) | Verfahren zur herstellung neuer spiro-oxazolidindione | |
CH653684A5 (fr) | Derives de carbostyrile, procede pour leur preparation et compositions les contenant. | |
US5250547A (en) | Benzopyran derivatives | |
DE19604920A1 (de) | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel | |
EP0222693A2 (de) | Neue 3-Oxadiazol- und 3-Carbonsäure-beta-Carbolinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel | |
EP0161599A2 (de) | Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
US4775695A (en) | Substituted amidinoalkoxy and amidinoalkylamino indanones and salts thereof | |
DE1795022C3 (de) | Lysergsäurederivate | |
EP0255028A2 (de) | Neue 1,4-Benzodiazepine, ihre Herstellung und Verwendung als PAF Antagonisten | |
EP0185909A1 (de) | 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0072960B1 (de) | 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0002672B1 (de) | Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
DE3721223C2 (sv) | ||
US4782054A (en) | Tetrahydroquinoline morpholine compounds, compositions and use | |
JP2684566B2 (ja) | 20,21―ジノルエブルナメニン誘導体の光学活性体の抗抑うつ剤としての使用及びそれらを含有する製薬組成物 | |
EP0146787B1 (de) | Indolderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
US5262422A (en) | Octahydrobenzo[g]quinoline | |
JP4216337B2 (ja) | ベンゾ[g]キノリン誘導体 | |
US4956365A (en) | Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds | |
HU200603B (en) | Process for producing substituted quinoxalinyl-imidazolidin-2,4-diones and pharmaceutical compositions comprising such compounds | |
US5240948A (en) | 3-(3-alkylthiopropyl)benzothiazoline derivatives, their preparation and the medicament containing them |